G. van Riper

发表

N-isonicotinoyl-(L)-4-aminophenylalanine derivatives as tight binding VLA-4 antagonists.

W. Hagmann, Kashmira Shah, R. Mumford, 2003, Bioorganic & medicinal chemistry letters.

N-Tetrahydrofuroyl-(L)-phenylalanine derivatives as potent VLA-4 antagonists.

M. Maccoss, S. D. de Laszlo, Bing Li, 2002, Bioorganic & medicinal chemistry letters.

N-aryl 2,6-dimethoxybiphenylalanine analogues as VLA-4 antagonists.

W. Hagmann, T. Kamenecka, R. Mumford, 2002, Bioorganic & medicinal chemistry letters.

Substituted tetrahydrofuroyl-1-phenylalanine derivatives as potent and specific VLA-4 antagonists.

M. Maccoss, W. Hagmann, John A. Schmidt, 2002, Bioorganic & medicinal chemistry letters.

The discovery of sulfonylated dipeptides as potent VLA-4 antagonists.

M. Maccoss, S. D. de Laszlo, J. Fenyk-Melody, 2001, Bioorganic & medicinal chemistry letters.

Amidines as amide bond replacements in VLA-4 antagonists.

M. Maccoss, S. D. de Laszlo, W. Hagmann, 2004, Bioorganic & medicinal chemistry letters.

A Small Molecule α4β1/α4β7 Antagonist Differentiates between the Low-Affinity States of α4β1 and α4β7: Characterization of Divalent Cation Dependence

S. D. de Laszlo, P. Detmers, C. Raab, 2003, Journal of Pharmacology and Experimental Therapeutics.

Substituted 3-amino biaryl propionic acids as potent VLA-4 antagonists.

M. Maccoss, W. Hagmann, K. Lyons, 2002, Bioorganic & medicinal chemistry letters.

Identification of unique VLA-4 antagonists from a combinatorial library.

S. D. de Laszlo, Bing Li, W. Hagmann, 2002, Bioorganic & medicinal chemistry letters.

Arginine 206 of the C5a Receptor Is Critical for Ligand Recognition and Receptor Activation by C-terminal Hexapeptide Analogs (*)

D. Underwood, J. Demartino, Z. Konteatis, 1995, The Journal of Biological Chemistry.

N-aryl-prolyl-dipeptides as potent antagonists of VLA-4.

M. Maccoss, S. D. de Laszlo, Bing Li, 2002, Bioorganic & medicinal chemistry letters.

Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of human RANTES but not human monocyte chemoattractant protein 1, human macrophage inflammatory protein 1 alpha, or human interleukin 8

D. Macintyre, H. Rosen, M. Springer, 1993, The Journal of experimental medicine.

Induction, characterization, and functional coupling of the high affinity chemokine receptor for RANTES and macrophage inflammatory protein-1 alpha upon differentiation of an eosinophilic HL-60 cell line.

D. Nicholson, H. Rosen, P. Fischer, 1994, Journal of immunology.

Characterization and species distribution of high affinity GTP-coupled receptors for human rantes and monocyte chemoattractant protein 1

H. Rosen, P. Fischer, M. Springer, 1993, The Journal of experimental medicine.

Development of C5a receptor antagonists. Differential loss of functional responses.

H. Rosen, Z. Konteatis, P. Fischer, 1994, Journal of immunology.

The amino terminus of the human C5a receptor is required for high affinity C5a binding and for receptor activation by C5a but not C5a analogs.

J. Demartino, H. Rosen, Z. Konteatis, 1994, The Journal of biological chemistry.

N-Tetrahydrofuroyl-(L)-phenylalanine derivatives as potent VLA-4 antagonists.

M. Maccoss, S. D. de Laszlo, W. Hagmann, 2002, Bioorganic & medicinal chemistry letters.

Construction and phosphorylation of a fusion protein Hu-IFN-alpha A/gamma.

S. Pestka, X. X. Zhao, J. Langer, 1989, Analytical biochemistry.

Two-site binding of C5a by its receptor: an alternative binding paradigm for G protein-coupled receptors.

J. Demartino, S. Bondy, H. Rosen, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Effects of VLA-4 antagonists in rat whole embryo culture.

W. Hagmann, L. Lin, John A. Schmidt, 2002, Teratology.

A small molecule alpha4beta1/alpha4beta7 antagonist differentiates between the low-affinity states of alpha4beta1 and alpha4beta7: characterization of divalent cation dependence.

S. D. de Laszlo, P. Detmers, C. Raab, 2003, The Journal of pharmacology and experimental therapeutics.

Substituted N-(3,5-dichlorobenzenesulfonyl)-L-prolyl-phenylalanine analogues as potent VLA-4 antagonists.

M. Maccoss, W. Hagmann, K. Lyons, 2002, Bioorganic & medicinal chemistry letters.

Substituted 3-amino biaryl propionic acids as potent VLA-4 antagonists.

M. Maccoss, W. Hagmann, K. Lyons, 2002, Bioorganic & Medicinal Chemistry Letters.

N-(arylacetyl)-biphenylalanines as potent VLA-4 antagonists.

Bing Li, M. Maccoss, S. D. de Laszlo, 2002, Bioorganic & medicinal chemistry letters.